Evidence map›Paper›PMID 26143245›Full record

Observational studySurgery today2016

Impact of inappropriate lymphadenectomy on lung metastasectomy for patients with metastatic colorectal cancer.

Sergi Call, Ramón Rami-Porta, Raúl Embún, Laura Casas, Juan J Rivas, Laureano Molins, José Belda-Sanchís

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Surgery today, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Role of video-assisted thoracoscopic surgery in pulmonary metastasectomy.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2022
    Article
  4. Observational
  5. Article
  6. Lymphadenectomy in pulmonary metastasectomy.Journal of thoracic disease · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sergi CallDepartment of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, Plaza Dr. Robert, 5, 08221, Terrassa, Barcelona, Spain. callsergi@me.com.ORCID http://orcid.org/0000-0002-5042-419X
Ramón Rami-PortaDepartment of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, and CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain.
Raúl EmbúnDepartment of Thoracic Surgery, Hospital Universitario Miguel Servet, and Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
Laura CasasDepartment of Biostatistics and Data Management, Dynamic, Madrid, Spain.
Juan J RivasDepartment of Thoracic Surgery, Hospital Universitario Miguel Servet, and Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
Laureano MolinsDepartment of Thoracic Surgery, Hospital Universitario Sagrat Cor and Hospital Clinic, Barcelona, Spain.
José Belda-SanchísDepartment of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, Plaza Dr. Robert, 5, 08221, Terrassa, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the characteristics of lymph node assessment in the Spanish Colorectal Metastasectomy Registry (GECMP-CCR) and to analyze and compare the survival of patients with pathological absence or presence of lymph node metastases (LNM) with the survival of those with uncertain lymph node status (uLNs).

methodsA total of 522 patients with lung metastases from colorectal carcinoma were prospectively registered from 2008 to 2010. To confirm the pathologic absence of LNM, systematic nodal dissection or systematic sampling was required, or the lymph node status was coded as uncertain. Disease-specific survival and disease-free survival were calculated by the Kaplan-Meier method with the log-rank test for comparisons.

resultsLymphadenectomy was performed in 250 (48%) patients. LNM was found in 25 (10%) of the patients who had lymph node assessment done. The 3- and 5-year disease-specific survival rates according to lymph node status were 73.5 and 58.3% in the absence of LNM, 50.5 and 24.8% when LNM was confirmed, and 69 and 44% for those with uLNs, respectively (p = 0.006).

conclusionsThe presence of LNM and uLNs is associated with an increased risk of death. The association of nodal assessment at the time of metastasectomy to identify LNM helps us to refine the postoperative prognosis; therefore, its impact should be properly studied in a prospective clinical trial.

Indexed as

Lymph Node ExcisionAgedCarcinomaColorectal NeoplasmsFemaleHumansLung NeoplasmsLymphatic MetastasisMaleMiddle AgedPneumonectomyPrognosisProspective StudiesSurvival RateColorectal cancerLymphadenectomyPulmonary metastases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.